SEC Tracker
Get the app

Skye Bioscience SKYE

Skye Bioscience: signs a material agreement, completes an acquisition or sale of assets and 4 other items

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 10.3
Material contract
Exhibit 10.4
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Completes an acquisition or sale of assets (2.01)
  • Takes on a new financial obligation (2.03)
  • Sells unregistered shares (3.02)
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Skye Bioscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Agenus AGEN public float $135M, Jun 30, 2025
  2. Vistagen Therapeutics VTGN public float $138M, Sep 30, 2025
  3. Kodiak Sciences KOD public float $122M, Jun 28, 2025
  4. Voyager Therapeutics VYGR public float $144M, Jun 30, 2025
  5. Eledon Pharmaceuticals ELDN public float $145M, Jun 30, 2025